PELP1: A Novel Therapeutic Target for Hormonal Cancers

被引：27
|
作者：
Chakravarty, Dimple [1 ]
Tekmal, Rajeshwar Rao [1 ]
Vadlamudi, Ratna K. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA
来源：
IUBMB LIFE | 2010年 / 62卷 / 03期
关键词：
estrogen receptor; coregulators; PELP1; hormonal signaling; therapy resistance; GLUTAMIC-ACID-RICH; RECEPTOR COACTIVATOR PELP1/MNAR; GROWTH-FACTOR REGULATION; RETRACTED ARTICLE. SEE; ESTROGEN-RECEPTOR; BREAST-CANCER; PROLINE-RICH; NONGENOMIC ACTIVITY; INTERACTING PROTEIN; COREGULATOR PELP1;
D O I：
10.1002/iub.287
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Recent studies implicate that the estrogen receptor (ER) coregulator proline-, glutamic acid-, and leucine-rich protein (PELP) 1 as playing critical roles in ER-genomic, ER-nongenomic, and ER-signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in hormonal cancers and recent studies further elucidated the molecular mechanisms by which PELP1 regulates hormone therapy response. Although PELP1 is important for normal functions of the ER, the possibility to target ER-PELP1 axis appears to be an effective strategy for preventing hormonal carcinogenesis and therapy resistance. Thus, PELP1 may be useful as prognostic marker for hormonal cancers and PELP1 signaling may be useful to generate targeted therapeutics to overcome hormonal therapy resistance. (C) 2009 IUBMB IUBMB Life, 62(3): 163-169, 2010
引用
收藏
页码：163 / 169
页数：7
相关论文
共 50 条
  • [21] A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Chakravarty, Dimple
    Krishnan, Samaya
    Liu, Zexuan
    Liu, Junhao
    Pratap, Uday P.
    Ebrahimi, Behnam
    Sanchez, John R.
    Li, Xiaonan
    Ma, Shihong
    Park, Ben H.
    Santhamma, Bindu
    Chen, Yidong
    Lai, Zhao
    V. Raj, Ganesh
    Yuan, Yaxia
    Zhou, Daohong
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar R.
    McHardy, Stan
    Huang, Tim H. -M.
    Rao, Manjeet K.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2022, 82 (20) : 3830 - 3844
  • [22] Regulation of rDNA Transcription by Proto-Oncogene PELP1
    Gonugunta, Vijay K.
    Nair, Binoj C.
    Rajhans, Rajib
    Sareddy, Gangadhara R.
    Nair, Sujit S.
    Vadlamudi, Ratna K.
    PLOS ONE, 2011, 6 (06):
  • [23] PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation
    Ning, Zhifeng
    Zhang, Youzhi
    Chen, Hanwei
    Wu, Jiliang
    Song, Tieshan
    Wu, Qian
    Liu, Fuxing
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [24] Significance of PELP1 in ER-Negative Breast Cancer Metastasis
    Roy, Sudipa
    Chakravarty, Dimple
    Cortez, Valerie
    De Mukhopadhyay, Keya
    Bandyopadhyay, Abhik
    Ahn, Jung-Mo
    Raj, Ganesh V.
    Tekmal, Rajeshwar R.
    Sun, LuZhe
    Vadlamudi, Ratna K.
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 25 - 33
  • [25] PELP1 oncogenic functions involve alternative splicing via PRIVIT6
    Mann, Monica
    Zou, Yi
    Chen, Yidong
    Brann, Darrell
    Vadlamudi, Ratna
    MOLECULAR ONCOLOGY, 2014, 8 (02) : 389 - 400
  • [26] Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
    Flageng, Marianne Hauglid
    Knappskog, Stian
    Gjerde, Jennifer
    Lonning, Per Eystein
    Mellgren, Gunnar
    PLOS ONE, 2015, 10 (08):
  • [27] Epigenetic modulation: a novel therapeutic target for overcoming hormonal therapy resistance
    Raha, Paromita
    Thomas, Scott
    Munster, Pamela N.
    EPIGENOMICS, 2011, 3 (04) : 451 - 470
  • [28] Central Role for PELP1 in Nonandrogenic Activation of the Androgen Receptor in Prostate Cancer
    Yang, Lin
    Ravindranathan, Preethi
    Ramanan, Meera
    Kapur, Payal
    Hammes, Stephen R.
    Hsieh, Jer-Tsong
    Raj, Ganesh V.
    MOLECULAR ENDOCRINOLOGY, 2012, 26 (04) : 550 - 561
  • [29] PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway
    Yan, Hongzhu
    Sun, Yanling
    Wu, Qian
    Wu, Zhe
    Hu, Meichun
    Sun, Yuanpeng
    Liu, Yusi
    Ma, Zi
    Liu, Shangqin
    Xiao, Wuhan
    Liu, Fuxing
    Ning, Zhifeng
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [30] The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
    Habashy, Hany Onsy
    Powe, Desmond G.
    Rakha, Emad A.
    Ball, Graham
    Macmillan, R. Douglas
    Green, Andrew R.
    Ellis, Ian O.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) : 603 - 612
12345